Met Life Investment Management, LLC Elanco Animal Health Inc Transaction History
Met Life Investment Management, LLC
- $18.1 Billion
- Q1 2025
A detailed history of Met Life Investment Management, LLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 8,851 shares of ELAN stock, worth $112,053. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,851
Previous 8,648
2.35%
Holding current value
$112,053
Previous $104,000
11.54%
% of portfolio
0.0%
Previous 0.0%
Shares
42 transactions
Others Institutions Holding ELAN
# of Institutions
410Shares Held
452MCall Options Held
718KPut Options Held
671K-
Dodge & Cox San Francisco, CA82.9MShares$1.05 Billion0.53% of portfolio
-
Primecap Management CO Pasadena, CA50.2MShares$636 Million0.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.3MShares$612 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$295 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A622MShares$279 Million11.21% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...